EOLS
EvolusCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
EOLS vs peer average
52/100
EOLS vs. peer average (C vs. C)
Grade spread
A 3 · C 2 · D 3 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
AMGN is the first available peer comparator.
Broad commercial-biopharma reference only; its scale and diversified portfolio make it a poor direct valuation comparable for Evolus.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
EOLS
Evolus
AMGN
Amgen
Grade
C
D
Momentum
70
93
Value
41
61
Sentiment
68
27
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs AMGN
EOLS / AMGN
Grade Position
In line
EOLS vs. peer average (C vs. C)
52/100
Momentum
70
AMGNValue
41
AMGNSentiment
68
EOLSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs EOLS
AMGN is the first peer returned for this comparison set.